For Immediate Release
Contacts:
Investors — Scott Pond (801) 345-2657, spond@nuskin.com
Media — Kara Schneck (801) 345-2116, kschneck@nuskin.com
NU SKIN ENTERPRISES TO BEGIN OPERATIONS IN CHILE
Latin American country marks company’s 54th international market
PROVO, Utah – Sept. 14, 2015 – Nu Skin Enterprises, Inc. today announced plans to open in Chile, expanding the company’s global operations to 54 international markets. A grand opening event is scheduled to take place in Santiago, Chile, on Nov. 2, 2015, where Nu Skin will introduce its personal care products to the market.
“Chile has become a strong direct selling market in Latin America, and we are optimistic it will be part of our continued growth in this region,” said Truman Hunt, president and chief executive officer. “We have built a healthy business in Latin America, and we look forward to introducing our scientifically advanced personal care products to consumers in this market. We believe the strength of our product portfolio will also attract business-minded individuals to our growing Latin American sales force.”
Initially, distributors and customers in Chile will be able to purchase from a select line of Nu Skin’s top-selling personal care products. The company plans to introduce products from its Pharmanex nutritional line in 2016.
About Nu Skin Enterprises, Inc.
Nu Skin Enterprises, Inc. demonstrates its tradition of innovation through its comprehensive anti-aging product portfolio, independent business opportunity and corporate social responsibility initiatives. The company’s scientific leadership in both skin care and nutrition has established Nu Skin as a premier anti-aging company. The company’s anti-aging products feature the ageLOC® line of products including ageLOC® Tru Face® Essence Ultra firming serum, the ageLOC® TR90® weight management and body shaping system, ageLOC® R2 nutritional supplement, and ageLOC® Transformation daily skin care system. A global direct selling company, Nu Skin operates in 53 markets worldwide and is traded on the New York Stock Exchange. More information is available at http://www.nuskin.com.
Please Note: This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that represent the company's current expectations and beliefs. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws and include, but are not limited to, statements of management's expectations regarding the Chile market, our business and product introductions in that market, and our performance in Latin America; statements of belief; and statements of assumptions underlying any of the foregoing. In some cases, you can identify these statements by forward-looking words such as "believe," "expect," "project," "anticipate," "estimate," "intend," "plan," "targets," "likely," "will," "would," "could," "may," "might," the negative of these words and other similar words.
The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to, the following:
· changes in operations or future financial results from those currently anticipated;
· any failure of current or planned initiatives or products to generate interest among the company's sales force and customers and generate sponsoring and selling activities on a sustained basis; and
· regulatory risks associated with the company's products, which could require the company to modify its claims or inhibit the company's ability to import or continue selling a product in a market if it is determined to be a medical device or if it is unable to register the product in a timely manner under applicable regulatory requirements.
The company's financial performance and the forward-looking statements contained herein are further qualified by a detailed discussion of associated risks set forth in the documents filed by the company with the Securities and Exchange Commission. The forward-looking statements set forth the company's beliefs as of the date that such information was first provided and the company assumes no duty to update the forward-looking statements contained in this release to reflect any change except as required by law.
# # #
